Department of Otolaryngology, Wuhan Third Hospital, Wuhan, 430000, Hubei, China.
Department of Head and Neck Radiation Therapy, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), No. 1 Banshan Road, Gongshu District, Hangzhou, 310021, Zhejiang, China.
Hum Cell. 2021 Mar;34(2):491-501. doi: 10.1007/s13577-020-00475-y. Epub 2021 Jan 5.
Nasopharyngeal carcinoma is a type of otolaryngological malignancy with high incidence. Long non-coding RNAs (lncRNAs) are closely related to nasopharyngeal carcinoma. LncRNA AFAP1-AS1 (AFAP1-AS1) has been found to play important roles in nasopharyngeal carcinoma progression and poor prognosis. However, the mechanism underlying AFAP1-AS1 in regulating nasopharyngeal carcinoma is still unclear. In current study, AFAP1-AS1 was found to be up-regulated in nasopharyngeal carcinoma tissues and cells. AFAP1-AS1 overexpression and knockdown were conducted in nasopharyngeal carcinoma cells. The results proved that AFAP1-AS1 promoted the survival and migration of nasopharyngeal carcinoma cells. Additionally, specificity protein 1 (SP1) was enhanced in nasopharyngeal carcinoma tissues and cells, and induced AFAP1-AS1 expression. The interaction between AFAP1-AS1 and miR-497-5p was confirmed. AFAP1-AS1 was demonstrated to regulate CELF1, a target gene of miR-497-5p. Further functional analysis revealed that AFAP1-AS1 knockdown attenuated SP1-induced nasopharyngeal carcinoma progression. These results indicate that SP1-induced AFAP1-AS1 facilitates nasopharyngeal carcinoma progression by regulating miR-497-5p/CELF1 pathway, which provides a new target for nasopharyngeal carcinoma treatment.
鼻咽癌是一种发病率较高的耳鼻喉恶性肿瘤。长链非编码 RNA(lncRNA)与鼻咽癌密切相关。长链非编码 RNA AFAP1-AS1(AFAP1-AS1)已被发现在鼻咽癌的发生发展和不良预后中发挥重要作用。然而,AFAP1-AS1 调节鼻咽癌的机制尚不清楚。在本研究中,发现 AFAP1-AS1 在鼻咽癌组织和细胞中呈上调表达。在鼻咽癌细胞中进行了 AFAP1-AS1 的过表达和敲低实验。结果证明 AFAP1-AS1 促进了鼻咽癌细胞的存活和迁移。此外,特异性蛋白 1(SP1)在鼻咽癌组织和细胞中增强,并诱导 AFAP1-AS1 的表达。证实了 AFAP1-AS1 与 miR-497-5p 之间的相互作用。证明 AFAP1-AS1 调节 miR-497-5p 的靶基因 CELF1。进一步的功能分析显示,AFAP1-AS1 的敲低减弱了 SP1 诱导的鼻咽癌进展。这些结果表明,SP1 诱导的 AFAP1-AS1 通过调节 miR-497-5p/CELF1 通路促进鼻咽癌的进展,为鼻咽癌的治疗提供了新的靶点。